Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 13, 2018 07:30 ET | Source: DarkPulse, Inc.

DarkPulse, Inc. Announces Investor Relations Campaign; Retains Experienced Texas Firm to Assist

NEW YORK, NY , Aug. 13, 2018 (GLOBE NEWSWIRE) -- DarkPulse, Inc. (OTC PINK: KLMK) today announced it has retained E & E Communications to assist with its investor relations program. “Our...
August 13, 2018 07:30 ET | Source: MYnd Analytics, Inc.

MYnd Analytics Provides Business Update for the Third Quarter of 2018

MISSION VIEJO, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND) (“MYnd” or the “Company”), a market leader in improving the delivery of mental health services and...
August 13, 2018 07:30 ET | Source: Ekso Bionics Holdings, Inc.

Ekso Bionics Appoints Jack Glenn as Chief Financial Officer

RICHMOND, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that John...
August 13, 2018 07:30 ET | Source: BioElectronics Corporation

BioElectronics Applies for FDA’s Opioid Alternative Innovation Challenge Program

FREDERICK, MD, Aug. 13, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, is pleased to announce that it has submitted an application to the U.S. Food and Drug...
August 13, 2018 07:30 ET | Source: Nephros, Inc.

Nephros Appoints Oliver Spandow to its Board of Directors

Seasoned Executive Adds Significant Operational and M&A Expertise SOUTH ORANGE, NJ, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device...
August 13, 2018 07:30 ET | Source: Moleculin Biotech, Inc.

Moleculin Biotech, Inc. Reports Financial Results for the Second Quarter Ended June 30, 2018

HOUSTON, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug...
August 13, 2018 07:30 ET | Source: Fundamental Markets

Research Report Identifies Hyatt Hotels, Entravision Communications, Pinnacle West Capital, Santander Consumer, DTE Energy, and Planet Fitness with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

NEW YORK, Aug. 13, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders,...
August 13, 2018 07:29 ET | Source: Athenex, Inc.

Athenex Pharma Solutions, an Athenex, Inc. Company, Launches Compounded Vasopressin Injection in Ready-to-Use Premix IV Bags

BUFFALO, N.Y., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for...
August 13, 2018 07:29 ET | Source: Nova Leap Health Corp.

Nova Leap Health Corp. Announces Execution of Definitive Agreement to Acquire Home Health Care Services Business in New England, U.S.

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Aug. 13, 2018 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or...
August 13, 2018 07:27 ET | Source: Reykjavíkurborg

Reykjavíkurborg - Útboð RVK 32 1 og RVKN 35 1 - viðhengi vantaði

Reykjavíkurborg hefur ákveðið í samræmi við útgáfuáætlun 2018 að efna til útboðs á skuldabréfaflokkum RVK 32 1 og RVKN 35 1 miðvikudaginn 15. ágúst. Heimild til lántöku á árinu 2018 er 6.611 m.kr. ...

1 ...148789 148790 148791 ...316267